This study reveals that METTL3‐mediated SREBP1c upregulation contributes to AKI and its progression to CKD through inducing mitochondrial energy metabolism dysfunction via transcriptionally suppressing YME1L1. The gene discussed is YME1L1; the disease is acute kidney injury.